Omega-3 supplementation in mild to moderate Alzheimer's disease: Effects on neuropsychiatric symptoms

International Journal of Geriatric Psychiatry

Volumn 23, Issue 2, 2008, Pages 161-169

  Freund Levi, Yvonne ^a   Basun, Hans ^b   Cederholm, Tommy ^b   Faxén Irving, Gerd ^a   Garlind, Anita ^a   Grut, Mikaela ^c   Vedin, Inger ^a   Palmblad, Jan ^a   Wahlund, Lars Olof ^a   Eriksdotter Jönhagen, Maria ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

Agitation; Alzheimer's disease; APOE; Dementia; Depression; DHA; EPA; Neuropsychiatric; Omega 3

Indexed keywords

ALPHA TOCOPHEROL; ANTIDEPRESSANT AGENT; APOLIPOPROTEIN E4; CHOLINESTERASE INHIBITOR; DOCOSAPENTAENOIC ACID; DONEPEZIL; EPAX1050TG; GALANTAMINE; HERBACEOUS AGENT; ICOSAPENTAENOIC ACID; NEUROLEPTIC AGENT; OMEGA 3 FATTY ACID; PLACEBO; RIVASTIGMINE; UNCLASSIFIED DRUG;

AGED; AGITATION; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; CAREGIVER BURDEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DIET SUPPLEMENTATION; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL SYMPTOM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROPSYCHIATRY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOMATOLOGY;

ACTIVITIES OF DAILY LIVING; AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; CHOLINESTERASE INHIBITORS; DEPRESSION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; GALANTAMINE; GENOTYPE; HUMANS; INDANS; MALE; PHENYLCARBAMATES; PIPERIDINES; PSYCHIATRIC STATUS RATING SCALES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 39749095115     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1857     Document Type: Article

References (48)